<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565149</url>
  </required_header>
  <id_info>
    <org_study_id>PBRC 25007</org_study_id>
    <secondary_id>2005-34323-15741</secondary_id>
    <nct_id>NCT00565149</nct_id>
  </id_info>
  <brief_title>PROOF: PROtein OverFeeding Effect on Body Weight</brief_title>
  <acronym>PROOF</acronym>
  <official_title>Dietary Protein Content Determines Weight Gain During High Fat Overfeeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Agriculture (USDA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine the effects of dietary protein content on overfeeding.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When body weight increases, the expenditure of energy increases as a mechanism to dissipate&#xD;
      the excess calories. The role of diet composition in over-feeding/energy dissipation in&#xD;
      humans is unknown. We propose that:&#xD;
&#xD;
        1. High and low protein diet will result in less weight gain as compared to a moderate&#xD;
           protein diet during a 56d high fat overfeeding.&#xD;
&#xD;
        2. Increase in energy expenditure and spontaneous physical activity, adjusted for lean and&#xD;
           fat mass will be greater in the high and low protein diets as compared to a moderate&#xD;
           protein diet.&#xD;
&#xD;
        3. the average size of the fat cells and the pattern of genes expressed in the adipose&#xD;
           tissue, skeletal muscle, and peripheral blood mononuclear cells will &quot;predict&quot; which&#xD;
           group of subjects will gain the most weight (and fat mass) independent of the level of&#xD;
           the protein in the diet.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the effect of overfeeding 40% above energy balance with a low (5%) or high (25%) vs. normal (15%) protein diet on body weight and body composition as well as energy expenditure and its components.</measure>
    <time_frame>baseline and after 8 weeks of overfeeding</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To relate the baseline characteristics of the subjects [fat cell size, pattern of gene expression, body composition, family history of obesity, etc] to the degree of weight / fat gain during overfeeding.</measure>
    <time_frame>baseline and after 8 Weeks of over feeding</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal Protein (15%) diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low Protein (5%) diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Protein (25%) diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PROOF</intervention_name>
    <description>dietary overfeeding with high, low or normal protein content</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <other_name>Overfeeding with different protein levels.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have a BMI of 19-30kg/m2 A cutpoint of 26kg/m2 will be used to allocate treatment&#xD;
             across the three diets. See the statistics section for more detail.&#xD;
&#xD;
          -  Are willing to eat all of the study foods even when full&#xD;
&#xD;
          -  Are willing to eat only foods provided by Pennington and all of the foods provided&#xD;
&#xD;
          -  Are willing to live at Pennington for 10-12 weeks possibly without leaving the&#xD;
             metabolic unit the entire time&#xD;
&#xD;
          -  Are willing to avoid exercise while in the inpatient phase of the study&#xD;
&#xD;
          -  Age 18 - 35&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Participants are ineligible to participate in the study if theyâ€¦&#xD;
&#xD;
          -  Smoke&#xD;
&#xD;
          -  Have Diabetes&#xD;
&#xD;
          -  Have claustrophobia&#xD;
&#xD;
          -  Have a Fasting Blood Sugar &gt;110&#xD;
&#xD;
          -  Have a history of cardiovascular disease&#xD;
&#xD;
          -  Have an average screening blood pressure &gt;140/90&#xD;
&#xD;
          -  Have a history of a major psychiatric, addictive or eating disorder or any&#xD;
             psychosocial or scheduling factors that could impede study outcomes&#xD;
&#xD;
          -  Post obese (self-reported BMI) must never have had a BMI greater than 32&#xD;
&#xD;
          -  Exercise more than 2 hours per week&#xD;
&#xD;
          -  Unable to complete VO2 max test.&#xD;
&#xD;
          -  Weight gain or loss of &gt; 3kg in the last 6 months&#xD;
&#xD;
          -  Have significant renal, hepatic, endocrine, pulmonary or hematological disease, or a&#xD;
             history of gout&#xD;
&#xD;
          -  Have had previous GI surgery, Obstructive disease of the GI tract, Hypermotility&#xD;
             disorder or a history of problems of impairment of the gag reflex.&#xD;
&#xD;
          -  Corticosteroid use in the last 2 Months&#xD;
&#xD;
          -  You are pregnant or breastfeeding&#xD;
&#xD;
          -  Have Irregular menstrual cycles&#xD;
&#xD;
          -  Use Depo-Provera, hormone implant or estrogen replacement therapy&#xD;
&#xD;
          -  Have an allergy to PABA (a component of a B-vitamin often found in sunscreen)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven R Smith, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 27, 2007</study_first_submitted>
  <study_first_submitted_qc>November 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2007</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Leanne Redman</investigator_full_name>
    <investigator_title>Professor, Adjunct</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

